Data and analytics play a crucial role in developing patient adherence programs by providing actionable insights and enabling data-driven decision-making.
Through our latest case study, see how this information was used to develop tailored push alerts that not only improved patient adherence but also boosted market share and sales outcomes for a new six-month dosage androgen deprivation therapy (ADT) injection launched in 2022. Gain strategic insights and recommendations for optimizing your own patient adherence strategies.
Download the full case study to discover how our strategic insights and advanced analytics are setting new benchmarks in patient care and commercial performance.
Author Team
EVERSANA employs a team of over 6000 professionals across 20+ locations around the world. From industry-leading patient service and adherence support to global pricing and revenue management, our team informs the strategies that matter…